We chose the MDA-MB-231 cells, an invasive and poorly differentiated triple-negative breast cancer cell line which lacks estrogen receptors (ER), progesterone receptors (PR), and the human epidermal growth factor receptors (HER2). The gene discussed is PGR; the disease is triple-negative breast carcinoma.